Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
MedInCell shares fell 1.7% this Tuesday midday, trading at 24.26 euros on Euronext Paris. This decline occurs as the Montpellier-based biotech has jus…
MedInCell stock is up 2.6% this Monday morning at 24.50 euros, following a major regulatory announcement in the United States. The Montpellier-based c…
Teva Pharmaceuticals and Medincell announce that the U.S. Food and Drug Administration has accepted the marketing authorization application for olanza…
MedInCell's stock significantly advanced this Thursday, February 19, trading at 24.50 euros midday, marking an increase of 2.25% from the previous day…
MedInCell shares fell by 3.52% this Monday, February 16, to 24.14 euros, amid a three-month correction period. The price is now significantly below it…
ISS ESG has upgraded the non-financial rating of Medincell from C+ to B, according to a press release from the French biotech published on Tuesday, Fe…
Medincell's stock has seen a significant decline of 21.5% over the past week, closing at 22.56 euros on Friday. This drop occurs in a context of high …
Stifel ajuste sa cible sur Medincell ce jeudi 29 janvier 2026.
Medincell's stock fell by 2.91% on Thursday afternoon, closing at 23.32 euros. This decline occurred amidst high volatility, with the stock losing 15.…
Medincell, through its partner Teva Pharmaceuticals, announces that the submission of a Marketing Authorization Application (MAA) for Olanzapine LAI i…
